Evidence map›Paper›PMID 40624153›Full record

ArticleScientific reports2025

Mechanism of Brucea javanica against multiple myeloma via TNF-NF-κB signaling.

Yuan Wang, Aijia Zhang, Yang Chen, Daoda Qi, Chengyi Peng, Zihao Liang, Jingjing Guo, Yan Gu, Hao Li

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuan Wang *Department of Geriatrics, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, PR China.
Aijia Zhang *Department of Geriatrics, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, PR China.
Yang Chen *Department of Geriatrics, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, PR China.
Daoda QiDepartment of Geriatrics, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, PR China.
Chengyi PengDepartment of Geriatrics, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, PR China.
Zihao LiangClinical Research Center, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, PR China.
Jingjing GuoDepartment of Geriatrics, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, PR China.
Yan GuDepartment of Geriatrics, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, PR China. guyan703@njucm.edu.cn.
Hao LiPhase I Clinical Experimental Research Center, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, PR China. mingyuehao@qq.com.

Funding

Geriatric Health Research Project of Jiangsu Provincial Health Commission No. LKM2022037Key Project of Research Project of Jiangsu Provincial Health Commission No. K2023018Nanjing Second Hospital Talent Promotion Project No. RCMS232013
6 · The paper itself

Abstract

This study aims to explore the pharmacological mechanism of Brucea javanica (BJ) in treating multiple myeloma (MM) through network pharmacology and validate this mechanism via in vitro experiments. Active pharmaceutical ingredients (APIs) of BJ and their potential targets were identified, along with MM-related targets. By plotting protein-protein interaction (PPI) networks, hub genes responsible for BJ in treating MM were identified and subjected to molecular docking. In MM cell lines H929 and U266, regulatory effects of BJ and luteolin (the major compound of BJ) on the behaviors of MM cells were examined. BJ extract exhibited dose-dependent cytotoxicity against MM cells, with IC

Indexed as

BruceaMultiple MyelomaNF-kappa BPlant ExtractsSignal TransductionTumor Necrosis Factor-alphaApoptosisCell Line, TumorCell ProliferationHumansLuteolinMolecular Docking SimulationNetwork PharmacologyProtein Interaction MapsLuteolinNF-kappa BPlant ExtractsTumor Necrosis Factor-alphaBrucea javanicaLuteolinMultiple myelomaNetwork pharmacologyTNF/NF-κB signaling pathwayTraditional Chinese medicine

Identifiers

PMID40624153
PMCPMC12234659

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.